申请人:——
公开号:US20040242593A1
公开(公告)日:2004-12-02
1′-substituted cannabinoid derivatives of delta-8-tetrahydrocannabinol, delta-9-tetrahydrocannabinol, and delta-6a-10a-tetrahydrocannabinol that have affinity for the cannabinoid receptor type-1 (CB-1) and/or cannabinoid receptor type-2 (CB-2). Compounds having activity as either agonists or antagonists of the CB-1 and/or CB-2 receptors can be used for treating CB-1 or CB-2 mediated conditions.
1′-取代的大麻素衍生物,包括Δ-8-四氢大麻酚、Δ-9-四氢大麻酚和Δ-6a-10a-四氢大麻酚,它们对大麻素受体类型-1(CB-1)和/或大麻素受体类型-2(CB-2)具有亲和力。具有作为CB-1和/或CB-2受体的激动剂或拮抗剂活性的化合物可用于治疗CB-1或CB-2介导的病症。